Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-09-014039
Filing Date
2009-03-05
Accepted
2009-03-05 21:11:09
Documents
2
Period of Report
2009-02-27

Document Format Files

Seq Description Document Type Size
1 D. KIM - FORM 3 2/27/2009 rrd236336.html 3  
1 D. KIM - FORM 3 2/27/2009 rrd236336.xml 3 5392
2 POWER OF ATTORNEY rrd211947_239522.htm EX-24.1 3263
  Complete submission text file 0001181431-09-014039.txt   10518
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 8588758600
KIM DENNIS D (Reporting) CIK: 0001456750 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33415 | Film No.: 09660368